Do analysts agree on Avanos Medical (AVNs) stock's upside?
Avanos Medical Inc. $31.93. After Hours: $31.93. (0.00%) 0.00. Closed: Apr 14, 4:02:25 PM GMT-4 · USD · NYSE · Disclaimer. No data. close. search Compare to.
Where can I buy AVNs shares?
Avanos Medical stock price target cut to $57 from $60 at Raymond James Jan. 16, 2019 at 8:12 a.m. ET by Tomi Kilgore Avanos Medical upgraded to outperform from market perform at Raymond James
When is Avanos Medical's next quarterly earnings release?
Mar 26, 2022 · Their forecasts range from $36.00 to $45.00. On average, they anticipate Avanos Medical's stock price to reach $40.67 in the next year. This suggests a possible upside of 28.0% from the stock's current price. View analysts' price targets for Avanos Medical or view top-rated stocks among Wall Street analysts.
What kind of company is Avanos Medical?
Apr 08, 2022 · Analyst Forecast. According to 10 analysts, the average rating for AVNS stock is "Sell." The 12-month stock price forecast is 40.04, which is …
Is Avanos Medical a buy right now?
3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 1 sell ratin...
How has Avanos Medical's stock price been impacted by COVID-19?
Avanos Medical's stock was trading at $29.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (...
When is Avanos Medical's next earnings date?
Avanos Medical is scheduled to release its next quarterly earnings announcement on Friday, May 6th 2022. View our earnings forecast for Avanos Med...
How were Avanos Medical's earnings last quarter?
Avanos Medical, Inc. (NYSE:AVNS) released its quarterly earnings results on Tuesday, February, 22nd. The company reported $0.46 earnings per share...
What guidance has Avanos Medical issued on next quarter's earnings?
Avanos Medical issued an update on its FY 2022 earnings guidance on Wednesday, March, 16th. The company provided earnings per share (EPS) guidance...
What price target have analysts set for AVNS?
3 analysts have issued 12-month price targets for Avanos Medical's shares. Their forecasts range from $36.00 to $45.00. On average, they anticipate...
Who are Avanos Medical's key executives?
Avanos Medical's management team includes the following people: Joseph F. Woody , Chief Executive Officer & Executive Director Michael C. Greiner...
What is Joseph F. Woody's approval rating as Avanos Medical's CEO?
32 employees have rated Avanos Medical CEO Joseph F. Woody on Glassdoor.com . Joseph F. Woody has an approval rating of 51% among Avanos Medical's...
Who are some of Avanos Medical's key competitors?
Some companies that are related to Avanos Medical include Shandong Weigao Group Medical Polymer (SHWGF) , MSA Safety (MSA) , Establishment Labs...
Recently Viewed Tickers
Avanos Medical Inc
Visit a quote page and your recently viewed tickers will be displayed here.
Is Avanos Medical a buy right now?
Avanos Medical, Inc. operates as a medical technology company. It focuses on delivering clinically medical device solutions to improve patients' quality of life.
What stocks does MarketBeat like better than Avanos Medical?
3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Avanos Medical stock.
When is Avanos Medical's next earnings date?
Wall Street analysts have given Avanos Medical a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Avanos Medical wasn't one of them.
How were Avanos Medical's earnings last quarter?
Avanos Medical is scheduled to release its next quarterly earnings announcement on Tuesday, November 2nd 2021.#N#View our earnings forecast for Avanos Medical.
How has Avanos Medical's stock price been impacted by COVID-19 (Coronavirus)?
Avanos Medical, Inc. (NYSE:AVNS) posted its quarterly earnings data on Monday, August, 2nd. The company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.23 by $0.02. The firm earned $186.40 million during the quarter, compared to the consensus estimate of $180.56 million.
What guidance has Avanos Medical issued on next quarter's earnings?
Avanos Medical's stock was trading at $29.01 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AVNS shares have increased by 8.4% and is now trading at $31.46.#N#View which stocks have been most impacted by COVID-19.
What price target have analysts set for AVNS?
Avanos Medical updated its FY 2021 earnings guidance on Tuesday, August, 10th. The company provided EPS guidance of $1.100-$1.200 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.210. The company issued revenue guidance of $729.10 million-$743.39 million, compared to the consensus revenue estimate of $741.22 million.
About AVNS
3 equities research analysts have issued 1 year price targets for Avanos Medical's stock. Their forecasts range from $41.00 to $47.00. On average, they anticipate Avanos Medical's stock price to reach $44.33 in the next twelve months.
Financial Performance
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
Analyst Forecast
In 2020, Avanos Medical's revenue was $714.80 million, an increase of 2.47% compared to the previous year's $697.60 million. Losses were -$27.20 million, -40.74% less than in 2019.
News
According to 7 analysts, the average rating for Avanos Medical stock is "Buy." The 12-month stock price forecast is 43.00, which is an increase of 30.30% from the latest price.
Premium Research for AVNS
Avanos Medical's (AVNS) second-quarter 2021 results gains from strength in Pain Management segment.
Company Summary
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
